Cargando…
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. It is unclear how progression of NAFLD towards cirrhosis translates into systematic changes in circulating proteins. Here, we provide a detailed proteo-transcriptomic map...
Autores principales: | Govaere, Olivier, Hasoon, Megan, Alexander, Leigh, Cockell, Simon, Tiniakos, Dina, Ekstedt, Mattias, Schattenberg, Jörn M., Boursier, Jerome, Bugianesi, Elisabetta, Ratziu, Vlad, Daly, Ann K., Anstee, Quentin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132975/ https://www.ncbi.nlm.nih.gov/pubmed/37037945 http://dx.doi.org/10.1038/s42255-023-00775-1 |
Ejemplares similares
-
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
por: Johnson, Katherine, et al.
Publicado: (2021) -
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
por: McGlinchey, Aidan J., et al.
Publicado: (2022) -
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
por: Sen, Partho, et al.
Publicado: (2022) -
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019) -
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)